Monograph Details
|
|
Ob/Gyn
> Vaginal infections
|
|
VAGISTAT-1 |
| Manufacturer |
|
Bristol-Myers Squibb |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Azole antifungal. |
| Generic Name |
|
Tioconazole 6.5%; vaginal oint. |
| Indications |
|
Vulvovaginal candidiasis. |
| Children |
|
Not recommended. |
| Adults |
|
1 applicatorful vaginally at bedtime. |
| Precautions |
|
Avoid use of tampons, diaphragms, or condoms for 72 hours after use. Confirm diagnosis with KOH smears and/or culture. Before retreatment, reconfirm diagnosis. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Vaginal burning, itching, dysuria, dyspareunia. |
| How Supplied |
|
Prefilled applicator (300mg)—1 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
